Crinetics Pharmaceuticals
Healthcare & Life Sci
Company overview
Crinetics Pharmaceuticals develops drugs for endocrine diseases, disorders of hormone-producing glands. Its pipeline includes paltusotine, a pill that blocks a hormone receptor called SST2, and atumelnant, a pill that blocks the ACTH hormone. The company is based in the United States.
Scott Struthers, Frank Zhu, Ana Kusnetzow and Stephen F. Betz founded Crinetics in 2008. The company had 437 employees and made $9.4 million in revenue in 2024. Vertex Pharmaceuticals bought Crinetics in July 2026, for $10 billion. That means a small drug developer with under $10 million in yearly sales became part of a much larger pharmaceutical company almost overnight. Historically, the median salary is ~$182,500.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States